Iran To Produce New Heavy Water-Based Radiopharmaceuticals


The head of the Atomic Energy Organization of Iran unveiled plans to develop new homegrown radiopharmaceuticals on the basis of heavy water. 

Speaking to reporters on the sidelines of a cabinet session on Wednesday, Mohammad Eslami said one of the plans on the agenda is to produce new medicinal radiocompounds on the basis of heavy water for the diagnosis and treatment of diseases.

He noted that one million patients receive treatment every year with the use of radiopharmaceuticals.

Eslami said the fact that the sole Iranian company producing radiopharmaceuticals has become subject to foreign sanctions indicates that those imposing sanctions do not place any value on the lives of people.

A few days ago, Eslami said Iran aims to become a global hub for manufacturing deuterium drugs.

“In a not too distant future we will turn into a hub for manufacturing drugs based on deuterium which are good alternatives to chemical drugs and have lower side effects in comparison (to those drugs),” he stated.

The AEOI launched a second phase of its deuterium production unit in Arak Heavy Water Reactor Facility in central Iran in April 2021.

Tasnim News Agency

Tasnim News Agency, which claims to be a private news agency in Iran but is reported be close to the IRGC, was launched in 2012. Its purpose is to cover a variety of political, social, economic and international subjects along with other fields.

Leave a Reply

Your email address will not be published. Required fields are marked *